Tritonpoint Wealth »

Castle Biosciences shares owned by Tritonpoint Wealth

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Tritonpoint Wealth from 13F filings

Historical chart of Tritonpoint Wealth investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Tritonpoint Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Tritonpoint Wealth

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 92k 22.07
2023-12-31 $2.0M 94k 21.58

More positions owned by Tritonpoint Wealth

Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Broadstone Net Lease (BNL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Growth Etf (VUG)
Danaher Corporation (DHR)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Accenture Plc Ireland Shs Class A (ACN)
United Parcel Service CL B (UPS)
Mastercard Incorporated Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Tritonpoint Wealth

Top funds holding Castle Biosciences

Daniel D. Thurber
Principal Financial Group
Vanguard Group
Bellevue Group
Deerfield Management Company
Portolan Capital Management
Millennium Management
Dimensional Fund Advisors
Kornitzer Capital Management
Palisade Capital Management
Jacobs Levy Equity Management
Citadel Advisors
New York State Common Retirement Fund
Charles Schwab Investment Management
Banque Pictet & Cie Sa

View all funds holding Castle Biosciences